By: Joshua P. Cohen
WASHINGTON, DC: The Biden Administration announced a plan on November 26, 2024, to cover obesity ... [+] drugs in Medicare and Medicaid. (Photo by Win McNamee/Getty Images)
Joshua Cohen is an independent healthcare analyst and writer for Forbes. With a focus on healthcare policy, drug pricing, and reimbursement, Joshua provides insightful analysis and commentary on the current state of the U.S. healthcare system. He is known for his centrist perspective and extensive knowledge in the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Joshua Cohen's focus is predominantly on the healthcare and pharmaceutical industry, particularly with an emphasis on legal policy regulations and government announcements. His articles often cite data to support his coverage.
When reaching out to Joshua, consider providing insights from experts in the healthcare sector who can offer data-driven analysis or commentary related to drug pricing, public health policies, or regulatory changes within the industry. Additionally, pitches addressing significant government announcements impacting healthcare and pharmaceuticals may align well with his coverage preferences.
While not explicitly stated, it’s clear that Joshua has a keen interest in YouTube channels as per one of his article titles. If you have relevant insights into this aspect of media consumption that intersects with healthcare topics covered by him, it might be worth incorporating such angles into your pitches.
This information evolves through artificial intelligence and human feedback. Improve this profile .